Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migranal for Acute Migraine with Cutaneous Allodynia
NCT00335777Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Aug 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dihydroergotamine in migraine (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Number of Subjects Who Were Pain Free at 2 Hours Post Treatment With Study Drug. Started Aug 2006; status: completed.
02
Drugs
dihydroergotamine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00335777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335777.